These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Impact of COVID-19 in solid organ transplant recipients. Danziger-Isakov L; Blumberg EA; Manuel O; Sester M Am J Transplant; 2021 Mar; 21(3):925-937. PubMed ID: 33319449 [TBL] [Abstract][Full Text] [Related]
46. First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study. Tschopp J; L'Huillier AG; Mombelli M; Mueller NJ; Khanna N; Garzoni C; Meloni D; Papadimitriou-Olivgeris M; Neofytos D; Hirsch HH; Schuurmans MM; Müller T; Berney T; Steiger J; Pascual M; Manuel O; van Delden C; Am J Transplant; 2020 Oct; 20(10):2876-2882. PubMed ID: 32412159 [TBL] [Abstract][Full Text] [Related]
47. A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients. Linares L; Cofan F; Diekmann F; Herrera S; Marcos MA; Castel MA; Farrero M; Colmenero J; Ruiz P; Crespo G; Llopis J; Garcia-Vidal C; Soriano À; Moreno A; Bodro M; PLoS One; 2021; 16(3):e0247251. PubMed ID: 33657157 [TBL] [Abstract][Full Text] [Related]
49. Early experience of COVID-19 in 2 heart transplant recipients: Case reports and review of treatment options. Holzhauser L; Lourenco L; Sarswat N; Kim G; Chung B; Nguyen AB Am J Transplant; 2020 Oct; 20(10):2916-2922. PubMed ID: 32378314 [TBL] [Abstract][Full Text] [Related]
50. An early experience on the effect of solid organ transplant status on hospitalized COVID-19 patients. Nair V; Jandovitz N; Hirsch JS; Abate M; Satapathy SK; Roth N; Miyara SJ; Guevara S; Kressel AM; Xiang A; Wu G; Butensky SD; Lin D; Williams S; Bhaskaran MC; Majure DT; Grodstein E; Lau L; Nair G; Fahmy AE; Winnick A; Breslin N; Berlinrut I; Molmenti C; Becker LB; Malhotra P; Gautam-Goyal P; Lima B; Maybaum S; Shah SK; Takegawa R; Hayashida K; Shinozaki K; Teperman LW; Molmenti EP; Am J Transplant; 2021 Jul; 21(7):2522-2531. PubMed ID: 33443778 [TBL] [Abstract][Full Text] [Related]
51. COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management. Miarons M; Larrosa-García M; García-García S; Los-Arcos I; Moreso F; Berastegui C; Castells L; Pérez-Hoyos S; Varela J; Pau-Parra A; Varón-Galcera C; Parramon-Teixidó CJ; Martínez-Casanova J; Domènech L; García-Ortega P; Sánchez-Sancho P; Alonso-Martínez C; Gómez-Ganda L; Roch-Santed M; Gracia-Moya A; Del-Rio-Gutiérrez JM; Guillén-Del-Castillo A; Sans-Pola C; Antón A; Montoro B; Gorgas-Torner MQ; Transplantation; 2021 Jan; 105(1):138-150. PubMed ID: 32941394 [TBL] [Abstract][Full Text] [Related]
56. Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients. Salerno DM; Jennings DL; Lange NW; Kovac DB; Shertel T; Chen JK; Hedvat J; Scheffert J; Brown RS; Pereira MR Am J Transplant; 2022 Aug; 22(8):2083-2088. PubMed ID: 35278260 [TBL] [Abstract][Full Text] [Related]
57. Quantifying excess deaths among solid organ transplant recipients in the COVID-19 era. Massie AB; Werbel WA; Avery RK; Po-Yu Chiang T; Snyder JJ; Segev DL Am J Transplant; 2022 Aug; 22(8):2077-2082. PubMed ID: 35294799 [TBL] [Abstract][Full Text] [Related]
59. COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges. Abu Jawdeh BG Adv Chronic Kidney Dis; 2020 Sep; 27(5):383-389. PubMed ID: 33308503 [TBL] [Abstract][Full Text] [Related]
60. Utilization and outcomes of deceased donor SARS-CoV-2-positive organs for solid organ transplantation in the United States. Schold JD; Koval CE; Wee A; Eltemamy M; Poggio ED Am J Transplant; 2022 Sep; 22(9):2217-2227. PubMed ID: 35730252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]